Independent clinic intelligence
Know more before you book.
Source-backed reporting on clinic selection, emerging compounds, pricing, evidence, and the questions a patient should ask before paying.
Current coverage
Latest patient guides
Practical reporting written to help patients check the clinician, product, pharmacy, price, and follow-up plan.
-
Phoenix Peptide Clinic Verification: Arizona License, NPI, and Pharmacy Checklist
Use this Phoenix clinic check card to verify a clinician’s Arizona license, action history, NPI, pharmacy permit, product status, written price, and follow-up before you pay.
-
Austin Peptide Clinic Verification: License, NPI, and Pharmacy Checklist
Use this Austin clinic check card to verify a clinician’s Texas license, NPI, pharmacy, product status, written price, and follow-up before you pay.
-
Peptide Clinic Pricing: What to Ask Before You Pay
Compare written clinic quotes with a total-cost worksheet. Separate known charges from unquoted items and check billing, pharmacy, and cancellation details.
-
Sermorelin Cost in 2026: 4 Programs Compared
Compare four advertised sermorelin programs, what each price includes, and the FDA history and pharmacy questions to check before paying.
-
FDA Peptide Vote Fallout: What Patients Should Ask Clinics Now
What the July 2026 FDA advisory vote did and did not change, the four-stage process from nomination to rulemaking, and five questions to test a clinic’s claim.
-
FDA Advisory Panel Peptide Vote (July 2026): Evidence Cards for BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon, and Emideltide
The July 2026 FDA peptide advisory vote was not FDA approval. Read the compound-by-compound evidence cards for BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon, and Emideltide.
-
How to Verify a Peptide Clinic’s NPI Record: Step-by-Step Guide
Learn how to verify a peptide clinic’s NPI record in under three minutes. Free step-by-step guide to the CMS NPI registry, state license cross-checks, and red flags to watch for…
-
Retatrutide Price: Why No Official Retail Price Exists Yet
Retatrutide is not FDA approved and has no manufacturer list price. This guide separates trial access, unapproved sales, research-use labels, compounding claims, and a future retail price.
-
Retatrutide Side Effects: What Phase 3 Shows in 2026
Retatrutide side effects: compare published Phase 2 findings, sponsor-reported Phase 3 results, FDA status and important limits of the evidence.
-
Retatrutide Near Me: Trials, Status, and Red Flags
Retatrutide is not FDA-approved and cannot be compounded. Learn how to find registered trials, expanded access information, and seller red flags.
Use the reporting. Then compare clinics.
Browse the city directories and check the public source behind each listing before you book.